In 2000, Dr. John B. Buse, Head of Endocrinology at the University of North Carolina at Chapel Hill, wrote a letter to the FDA warning that Avandia showed "an alarming trend in cardiovascular death and severe side effects" among patients taking medication.
In July 2001, the FDA sent a Glaxo letter stating that the company's sales representative had minimized drug safety issues. If you are also suffering from diabetes drugs and want to file a case against Avandia manufactures then you can contact with various diabetes drug lawyers.
The FDA asked Glaxo to send a letter to doctors prescribing Avandia warning them about the serious risks involved with taking the drug.
It seems that both the FDA and the maker of Avandia have known about the potential cardiovascular risks associated with drugs for more than six years but have not adequately warned doctors and consumers about the lethal effects of these drugs. Back in 2000, Dr.
Buse told the FDA that he criticized Glaxo and accused the company of making "pervasive and systemic" efforts to minimize the benefits of drugs and overestimate the benefits of drugs. The FDA sent a warning letter to the doctor, but no more decisive action was taken, and the drug continued to be prescribed throughout the world.
Lawyers for Glaxo said they had received calls from Avandia users and estimated that future lawsuits could reach tens of billions of dollars. Plaintiffs' attorneys will definitely link the warning years about cardiovascular risk which are all ignored by Avandia makers.